Academic Highlights: Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion.
J Clin Psychiatry 2004;65(11):1565-1574
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Click to enlarge page
By highlighting issues from presentations he delivered in the 1980s, Dr. Rosenbaum provided an overview of benzodiazepine use. He stated that benzodiazepines were and still are widely used and offer symptomatic relief for some of humankind’s most prevalent and distressing conditions. One thing that has changed, Dr. Rosenbaum commented, is pharmacologic alternatives.